Related Experiment Video

Updated: Jul 12, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

New treatment strategies for proliferative lupus nephritis: keep children in mind!

B Ranchin1, S Fargue

  • 1Paediatric Nephrology Unit, Centre de Référence des Maladies Rénales Héréditaires, Hospices Civils de Lyon and Université Lyon 1, Lyon, France. bruno.ranchin@chu-lyon.fr

Lupus
|August 23, 2007
PubMed

Insights

Children with lupus nephritis often face kidney complications. Current treatments, based on adult data, carry risks, necessitating research into safer, pediatric-specific therapies for lupus nephritis.

Area of Science:

  • Pediatric Nephrology
  • Rheumatology
  • Immunology

Background:

  • Renal involvement, or lupus nephritis, is common in children with systemic lupus erythematosus (SLE).
  • Existing treatment protocols for proliferative glomerulonephritis are primarily derived from adult studies, often involving high-dose cyclophosphamide (CYC) and steroids, which can lead to severe adverse effects in pediatric patients.
  • Limited data exists on novel therapeutic strategies in children, despite their investigation in adult SLE populations.

Purpose of the Study:

  • To highlight the frequent occurrence and significant morbidity associated with renal involvement in pediatric systemic lupus erythematosus (SLE).
  • To underscore the limitations of current treatment strategies for lupus nephritis in children, which are largely extrapolated from adult studies.
  • To advocate for the development and validation of less toxic, pediatric-specific therapeutic regimens for lupus nephritis.

Main Methods:

  • Review of existing literature on renal involvement in pediatric SLE and treatment strategies for lupus nephritis.
  • Discussion of conventional treatment regimens (high-dose cyclophosphamide and steroids) and their associated toxicities in children.
  • Exploration of emerging therapeutic strategies being investigated in adult lupus nephritis, including sequential therapies with various agents like calcineurin inhibitors, mycophenolate mofetil, azathioprine, and rituximab.

Main Results:

  • Pediatric lupus nephritis is associated with substantial short- and long-term morbidity.
  • Conventional treatments for proliferative glomerulonephritis in children carry significant risks of severe side effects.
  • There is a paucity of data regarding the efficacy and safety of novel therapeutic agents in pediatric lupus nephritis.

Conclusions:

  • Establishing international registries and conducting controlled trials are crucial for understanding the long-term prognosis of childhood lupus nephritis.
  • Validation of less toxic therapeutic regimens tailored for children is imperative.
  • Further research is needed to optimize treatment strategies and improve outcomes for children with lupus nephritis.

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...